M. Schroeder

4.2k total citations
60 papers, 2.4k citations indexed

About

M. Schroeder is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M. Schroeder has authored 60 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 18 papers in Molecular Biology and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M. Schroeder's work include Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Research Studies (10 papers) and Cancer Genomics and Diagnostics (9 papers). M. Schroeder is often cited by papers focused on Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Research Studies (10 papers) and Cancer Genomics and Diagnostics (9 papers). M. Schroeder collaborates with scholars based in Germany, Spain and United States. M. Schroeder's co-authors include Núria López-Bigas, Abel González-Pérez, David Tamborero, Jordi Deu-Pons, Christian Perez-Llamas, Carlota Rubio-Pérez, Alberto Santos, Alba Jené-Sanz, Andreas Dietz and Volker Rudat and has published in prestigious journals such as Journal of Clinical Oncology, Environmental Science & Technology and Blood.

In The Last Decade

M. Schroeder

53 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Schroeder Germany	23	955	634	608	578	464	60	2.4k
Youn Soo Lee South Korea	26	671 0.7×	334 0.5×	522 0.9×	406 0.7×	488 1.1×	130	2.2k
Michael R. Cooper United States	29	1.3k 1.3×	649 1.0×	1.3k 2.1×	1.2k 2.0×	360 0.8×	104	3.8k
Monica Mangoni Italy	24	353 0.4×	669 1.1×	760 1.3×	616 1.1×	294 0.6×	115	2.3k
Anikó Kovács Sweden	28	863 0.9×	856 1.4×	919 1.5×	300 0.5×	251 0.5×	108	2.6k
Min Sun China	24	808 0.8×	541 0.9×	351 0.6×	505 0.9×	421 0.9×	111	2.3k
Pierre Tennstedt Germany	34	929 1.0×	600 0.9×	787 1.3×	2.0k 3.5×	467 1.0×	134	3.5k
Mats G. Karlsson Sweden	32	854 0.9×	450 0.7×	751 1.2×	423 0.7×	673 1.5×	97	2.7k
Geno Saccomanno United States	26	1.6k 1.7×	657 1.0×	683 1.1×	1.0k 1.8×	241 0.5×	58	3.3k
Myoung Hee Kang South Korea	25	885 0.9×	337 0.5×	857 1.4×	322 0.6×	261 0.6×	63	2.1k
Minghua Ge China	23	653 0.7×	347 0.5×	423 0.7×	168 0.3×	462 1.0×	86	1.7k

Countries citing papers authored by M. Schroeder

Since Specialization

Citations

This map shows the geographic impact of M. Schroeder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Schroeder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Schroeder more than expected).

Fields of papers citing papers by M. Schroeder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Schroeder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Schroeder. The network helps show where M. Schroeder may publish in the future.

Co-authorship network of co-authors of M. Schroeder

This figure shows the co-authorship network connecting the top 25 collaborators of M. Schroeder. A scholar is included among the top collaborators of M. Schroeder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Schroeder. M. Schroeder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Neumann, Martín, Patrícia M. A. Silva, Jutta Ortiz-Tánchez, et al.. (2023). FAT1 expression in T-cell acute lymphoblastic leukemia (T-ALL) modulates proliferation and WNT signaling. Scientific Reports. 13(1). 972–972. 5 indexed citations

Schroeder, M., Sonja Hänzelmann, Lorenz Bastian, et al.. (2022). An alternative CYB5A transcript is expressed in aneuploid ALL and enriched in relapse. BMC Genomic Data. 23(1). 30–30. 1 indexed citations

Schroeder, M., et al.. (2019). ABSTRACTS OF THE 7^TH INTERNATIONAL CONFERENCE ON ADVANCES IN HEMATOLOGY AND ONCOLOGY (ICAHO2019). Anticancer Research. 39(10). 5841–5851.

Groeneveld‐Krentz, Stefanie, M. Schroeder, Michael J. Reiter, et al.. (2019). Aneuploidy in children with relapsed B‐cell precursor acute lymphoblastic leukaemia: clinical importance of detecting a hypodiploid origin of relapse. British Journal of Haematology. 185(2). 266–283. 16 indexed citations

Vidal, Enrique, Sergi Sayols, Sebastián Morán, et al.. (2017). A DNA methylation map of human cancer at single base-pair resolution. Oncogene. 36(40). 5648–5657. 70 indexed citations

Neumann, Martín, Sebastian Vosberg, Alva Rani James, et al.. (2016). Molecular alterations in bone marrow mesenchymal stromal cells derived from acute myeloid leukemia patients. Leukemia. 31(5). 1069–1078. 81 indexed citations

Rubio-Pérez, Carlota, David Tamborero, M. Schroeder, et al.. (2015). In Silico Prescription of Anticancer Drugs to Cohorts of 28 Tumor Types Reveals Targeting Opportunities. Cancer Cell. 27(3). 382–396. 217 indexed citations

González-Pérez, Abel, Christian Perez-Llamas, Jordi Deu-Pons, et al.. (2013). IntOGen-mutations identifies cancer drivers across tumor types. Nature Methods. 10(11). 1081–1082. 383 indexed citations

Schroeder, M., Abel González-Pérez, & Núria López-Bigas. (2013). Visualizing multidimensional cancer genomics data. Genome Medicine. 5(1). 9–9. 66 indexed citations

10.

Gauler, Thomas, Viktor Gruenwald, Axel Matzdorff, et al.. (2013). Phase II Study of Cetuximab in Combination with Docetaxel in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck after Platinum-Containing Therapy: A Multicenter Study of the Arbeitsgemeinschaft Internistische Onkologie. Oncology. 84(5). 284–289. 34 indexed citations

11.

Schroeder, Alexander D., E. Sebastian Debus, M. Schroeder, & W. Reinpold. (2012). Laparoscopic transperitoneal sublay mesh repair: a new technique for the cure of ventral and incisional hernias. Surgical Endoscopy. 27(2). 648–654. 70 indexed citations

12.

Schroeder, M. & Carlo Aul. (2005). Antiangiogenetische Therapie eines Nieren-Angiomyolipoms bei einer schwerstbehinderten Patientin mit Multipler Sklerose. Aktuelle Urologie. 36(5). 430–432. 2 indexed citations

13.

Stahl, M., H. Wilke, Martin Stuschke, et al.. (2004). Clinical response to induction chemotherapy predicts local control and long-term survival in multimodal treatment of patients with locally advanced esophageal cancer. Journal of Cancer Research and Clinical Oncology. 131(1). 67–72. 43 indexed citations

14.

Honecker, Friedemann, Christian Kollmannsberger, D. Quietzsch, et al.. (2002). Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer. Anti-Cancer Drugs. 13(5). 497–503. 44 indexed citations

15.

Staar, S., Volker Rudat, Hartmut Stuetzer, et al.. (2001). Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy—results of a multicentric randomized German trial in advanced head-and-neck cancer. International Journal of Radiation Oncology*Biology*Physics. 50(5). 1161–1171. 285 indexed citations

16.

Kollmannsberger, Christian, D. Quietzsch, Christian Haag, et al.. (2000). A phase II study of paclitaxel, weekly, 24-hour continuous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer. British Journal of Cancer. 83(4). 458–462. 101 indexed citations

17.

Gabius, Hans‐Joachim, Sigrun Gabius, S. K. Joshi, et al.. (1994). From Ill-Defined Extracts to the Immunomodulatory Lectin: Will There be a Reason for Oncological Application of Mistletoe?*. Planta Medica. 60(1). 2–7. 41 indexed citations

18.

Wolf, M., Maria Pritsch, P. Drings, et al.. (1991). Cyclic-alternating versus response-oriented chemotherapy in small-cell lung cancer: a German multicenter randomized trial of 321 patients.. Journal of Clinical Oncology. 9(4). 614–624. 33 indexed citations

19.

Wolf, M., C. Gropp, M. Maasberg, et al.. (1988). Ergebnisse zweier multizentrischer Therapiestudien beim inoperablen nichtkleinzelligen Bronchialkarzinom. Oncology Research and Treatment. 11(5). 222–231. 3 indexed citations

20.

Wolf, M., K. Havemann, Rolf Holle, et al.. (1987). Rezidivhäufigkeit und Langzeit-Überleben beim kleinzelligen Bronchialkarzinom. Oncology Research and Treatment. 10(6). 357–366. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact